# Clorazepate Dipotassium

NDC: 51672-4044
Generic name: Clorazepate Dipotassium
Labeler / Manufacturer: Taro Pharmaceuticals U.S.A., Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20000427

FDA application: ANDA075731

## Active ingredients

- CLORAZEPATE DIPOTASSIUM: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51672-4044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51672-4044
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=499a6989-8912-44b7-b1eb-ee8f85ae378f